|Articles|April 11, 2020

Recalls That Should Be on Your Radar—Week of April 5, 2020

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

We’ve compiled a list of recalls issued by the US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) from this past week:

Boston Scientific Corporation Issues Recall of Imager II Angiographic Catheters Due to Tip Detachment

Boston Scientific Corporation has issued a recall of Imager II angiographic catheters due to the possibility of tip detachment malfunctions. The catheters are used to deliver contrast agents to blood vessels including carotid arteries.

The catheter tip can become detached during a patient procedure or during procedure preparation. This may lead to additional procedures to remove the catheter tip from the patient’s blood vessel and increased the length of hospital stay. There is also the potential for serious adverse events including obstruction of embolism, stroke, or death.

There have been 9 injuries reported.

Read the recall statement.

H&C Food Inc. Issues Recall of Enoki Mushroom Because of Possible Health Risk

H&C Food has issued a recall of its enoki Mushroom due to the potential to be contaminated with Listeria monocytogenes.

Listeria monocytogenes can cause serious, even deadly, infections in older adults, the immunocompromised, and young children. In healthy individuals, there are typically only short term symptoms like fever, severe headache, nausea, stiffness, diarrhea, and abdominal pain.

No adverse health events have been reported to date in connection with this problem.

The products affected are enoki mushrooms from South Korea. The FDA began investigating an outbreak of Listeria associated with enoki mushrooms imported from South Korea which were sold by another firm in March.

Read the recall statement.


Related to this article

Measles Update: October 23, 2026
The latest CDC numbers show a 4.0% increase in measles cases from week-to-week, bringing the 2026 US total to 4588 confirmed cases. Ninety-six percent of cases are outbreak-associated.
Household Contacts Drive Most Hepatitis B Exposures in Young Children
Karen B. Jacobson, MD, MPH, of Kaiser Permanente Northern California, presented data at IDWeek 2026 showing 58.2% of children younger than five years exposed to active hepatitis B in the home were exposed by someone other than their birth mother, a risk maternal screening alone would miss under the CDC’s revised birth dose recommendation.
Inhaled Amikacin Shows Low Resistance Rates in MAC Lung Disease in ENCORE
In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while treatment-emergent amikacin (2.2%) and macrolide (1.1%) resistance stayed rare. Kevin Winthrop, MD, provides insights around the study.